GENE ONLINE|News &
Opinion
Blog

Deals
Funding Pfizer
Valneva Receives Funding From Pfizer to Develop World’s Only Lyme Disease Vaccine
2022-06-21
IPO China
Shenzhen Joincare Plots $300 Million IPO On Swiss Exchange
2022-06-20
Funding NASH
Akero Receives Up To $125 Million To Continue Liver Disease Treatment Development
2022-06-17
Licensing Greater China
Quion Licenses Two Rare Skin Disease Candidates to Hong Kong WinHealth
2022-06-16
Licensing MorphoSys
MorphoSys Thins Pipeline For Potential $1 Billion Deal While Progressing Oncology Ambitions
2022-06-16
Policy Antibiotic Resistance
UK Launches World-First Program With Two Antimicrobial Drugs to Counter Superbugs
2022-06-16
Funding Series B Funding
Dren Bio Draws $65 Million, Aiming for Phase 1 of ADCC Lead
2022-06-15
Funding Series B Funding
Elektrofi Secures $40 Million in Series B Funding For Drug Delivery Development
2022-06-15
Licensing China
Organon Licenses Biosimilars From Shanghai’s Henlius For $103 Million
2022-06-14
Funding Series A Funding
Series A Funding Successfully Wraps Up for Two Up-and-Coming Biotechs
2022-06-10
Licensing CDMO
Novartis and Samsung Biologics Sign Low-Profile $81 Million Deal
2022-06-10
IPO Funding
Forbion Looks to Fund IPO Ambitious Companies With Its €470 Million Fund
2022-06-10
Funding Gene Therapy
Astellas Ups Production of Gene Therapies With New Carolina Plant
2022-06-09
Partnerships Hepatitis C
Gilead Sciences Works Alongside Westminster Drug Project To Eliminate Hepatitis C
2022-06-09
M&A Supply Chain
EQT and Mubadala to Acquire Envirotainer in $3 Billion Deal
2022-06-08
1 … 17 18 19 20 21 … 47
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
READ MORE
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top